Shares of VolitionRX Limited (NYSEAMERICAN:VNRX – Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.28 and traded as low as $0.2660. VolitionRX shares last traded at $0.2850, with a volume of 6,574,460 shares changing hands.
VolitionRX Trading Up 13.5%
The company has a market cap of $37.33 million, a price-to-earnings ratio of -1.24 and a beta of 1.23. The firm’s 50-day moving average price is $0.28 and its 200 day moving average price is $0.47.
About VolitionRX
VolitionRX, traded as VNRX on the NYSE American exchange, is a pioneering life sciences company focused on the development and commercialization of minimally invasive diagnostic tests for the early detection of cancer and other diseases. Utilizing proprietary technology to analyze circulating nucleosomes in blood samples, the company’s platform identifies disease-specific epigenetic and biochemical signatures. By offering blood-based screening solutions, VolitionRX aims to deliver alternatives to invasive, costly and time-consuming procedures, potentially improving patient outcomes through earlier diagnosis.
The company’s flagship product suite, branded as Nu.Q, comprises assays designed to detect biomarkers associated with a range of malignancies, including colorectal, lung and pancreatic cancers, as well as other systemic conditions.
Read More
- Five stocks we like better than VolitionRX
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.
